Rajesh S. Gokhale

Rajesh S. Gokhale

Auto-generated profile, based on publicly available information

Rajesh S. Gokhale

Immunometabolism laboratory, National Institute of Immunology

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2018 in The EMBO Journal
Verified
Journal Article
Closed access
PDF file
RMRajender Motiani
Rajender Motiani
JTJyoti Tanwar
Jyoti Tanwar
DRDesingu Ayyappa Raja
Desingu Ayyappa Raja
AVAyushi Vashisht
Ayushi Vashisht
SKShivangi Khanna
Shivangi Khanna
RGRajesh S Gokhale
Rajesh S Gokhale

22 February 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
KMKritee Mehdiratta
Kritee Mehdiratta
SSShubham Singh
Shubham Singh
SSSachin Sharma
Sachin Sharma
RBRashmi S. Bhosale
Rashmi S. Bhosale
RCRahul Choudhury
Rahul Choudhury
RGRajesh S. Gokhale
Rajesh S. Gokhale
Significance: Mycobacterium tuberculosis ( Mtb ) is the etiological agent of human tuberculosis (TB). Mtb can persist inside host macrophages by successfully adapting to intracellular conditions. Acquisition of balanced amounts of essential micronutrients is one such important process. Our studies have identified a metallophore produced on demand to restore Mtb zinc metabolic imbalance. These diacyl-diisonitrile lipopeptides, named kupyaphores, are specifically induced during infection and move in and out of cells to protect bacteria from host-mediated nutritional deprivation and intoxication. Furthermore, we identify an Mtb isonitrile hydratase homolog , expressed in low-zinc conditions, which probably facilitates zinc release from kupyaphores. Identification of this zinc acquisition strategy could provide opportunities in future to understand systemic zinc dysbiosis and associated manifestations in TB patients.

29 August 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ASArchana Singh
Archana Singh
VGVishvabandhu Gotherwal
Vishvabandhu Gotherwal
PJPäivi Junni
Päivi Junni
VVVinaya Vijayan
Vinaya Vijayan
MTManisha Tiwari
Manisha Tiwari
RGRajesh S. Gokhale
Rajesh S. Gokhale
In vitiligo, chronic loss of melanocytes and consequent absence of melanin from the epidermis presents a challenge for long-term tissue maintenance. The stable vitiligo patches are known to attain an irreversible depigmented state. However, the molecular and cellular processes resulting in this remodeled tissue homeostasis is unclear. To investigate the complex interplay of inductive signals and cell intrinsic factors that support the new acquired state, we compared the matched lesional and non-lesional epidermis obtained from stable non-segmental vitiligo subjects. Hierarchical clustering of genome-wide expression of transcripts surprisingly segregated lesional and non-lesional samples in two distinct clades, despite the apparent heterogeneity in the lesions of different vitiligo subjects. Pathway enrichment showed the expected downregulation of melanogenic pathway and a significant downregulation of cornification and keratinocyte differentiation processes. These perturbations could indeed be recapitulated in the lesional epidermal tissue, including blunting of rete-ridges, thickening of stratum corneum and increase in the size of corneocytes. In addition, we identify marked increase in the putrescine levels due to the elevated expression of spermine/spermidine acetyl transferase. Our study provides insights into the intrinsic self-renewing ability of damaged lesional tissue to restore epidermal functionality in vitiligo.

18 May 2022 in PLOS Biology
Verified
Journal Article
Open access
PDF file
FSFarina Sultan
Farina Sultan
RBReelina Basu
Reelina Basu
DMDivya Murthy
Divya Murthy
MKManisha Kochar
Manisha Kochar
KAKuldeep S. Attri
Kuldeep S. Attri
RGRajesh S. Gokhale
Rajesh S. Gokhale
Therapeutic methods to modulate skin pigmentation has important implications for skin cancer prevention and for treating cutaneous hyperpigmentary conditions. Towards defining new potential targets, we followed temporal dynamics of melanogenesis using a cell-autonomous pigmentation model. Our study elucidates 3 dominant phases of synchronized metabolic and transcriptional reprogramming. The melanogenic trigger is associated with high MITF levels along with rapid uptake of glucose. The transition to pigmented state is accompanied by increased glucose channelisation to anabolic pathways that support melanosome biogenesis. SREBF1-mediated up-regulation of fatty acid synthesis results in a transient accumulation of lipid droplets and enhancement of fatty acids oxidation through mitochondrial respiration. While this heightened bioenergetic activity is important to sustain melanogenesis, it impairs mitochondria lately, shifting the metabolism towards glycolysis. This recovery phase is accompanied by activation of the NRF2 detoxication pathway. Finally, we show that inhibitors of lipid metabolism can resolve hyperpigmentary conditions in a guinea pig UV-tanning model. Our study reveals rewiring of the metabolic circuit during melanogenesis, and fatty acid metabolism as a potential therapeutic target in a variety of cutaneous diseases manifesting hyperpigmentary phenotype.

11 November 2019 in EMBO Reports
Verified
Journal Article
Open access
PDF file
DRDesingu Ayyappa Raja
Desingu Ayyappa Raja
VGVishvabandhu Gotherwal
Vishvabandhu Gotherwal
SBShaunak A Burse
Shaunak A Burse
YSYogaspoorthi J Subramaniam
Yogaspoorthi J Subramaniam
FSFarina Sultan
Farina Sultan
VNVivek Natarajan
Vivek Natarajan
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

16 December 2022 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
IGIti Gupta
Iti Gupta
SSShambhavi Shankrit
Shambhavi Shankrit
KNKiran Narta
Kiran Narta
MGMadeeha Ghazi
Madeeha Ghazi
RGRitika Grover
Ritika Grover
VNVivek Natarajan
Vivek Natarajan